Clinical Trial 46726

Aurora, CO 80045


<b>Multiple Sclerosis - Multiple Locations in the US</b>

    EMBOLD: Evaluating a Potential Approach for Progressive Forms of MS

    What’s next in research for non-active progressive MS
    The EMBOLD Study is evaluating a new potential investigational treatment designed for progressive MS that gets worse with time but doesn’t include relapses (non-active primary and secondary progressive multiple sclerosis).

    EMBOLD at a Glance
    • Up to 200 participants
    • Five years of participation
    • All participants will receive the investigational treatment at certain points in the study.
    You may be eligible if:*
    • You are aged 18 to 60 and diagnosed with progressive multiple sclerosis without relapses
    • You’ve never tried Lemtrada® (alemtuzumab), Mavenclad® (cladribine), stem cell transplant, or EBV T-cell therapy
    • You are able to walk 30 feet or more with or without the help of a cane or walker

    *Other eligibility criteria will apply.

    All participants will receive the investigational treatment and study-related care and monitoring at no cost. Travel support and reimbursements may also be available.

    Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.